UPDATE: Deutsche Bank Reiterates, Raises PT on LifePoint Hospitals Following In-Line Q3 Results
In a report published Monday, Deutsche Bank analyst Greg Poole reiterated a Hold rating on LifePoint Hospitals (NASDAQ: LPNT), and raised the price target from $55.00 to $56.00.
In the report, Deutsche Bank noted, “Underlying Q3 results were mostly in-line after taking into account slightly better HITECH pmts vs. expectations. While inpt vols remain soft due to pressure on 1-day stays, outpt trends were solid and SS organic rev growth returned to slightly positive territory (+0.8% YoY). LPNT faces a few discrete headwinds associated w/rural hospital funding in 2014, but we believe YoY EBITDA growth should inflect due to declines in uninsured (ACA) and visibility into a solid M&A pipeline. We've updated ests to reflect pending M&A, offset by reduced funding in N.M. and slightly lower HITECH. Nudging PT to $56 from $55, but maintain Hold on weaker rural hospital fundamentals.”
LifePoint Hospitals closed on Friday at $49.92.
(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.